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Abstract
Background: Insulin dysregulation (ID) and donkey metabolic syndrome (DMS) are 
common in this species. Contrary to horses, diagnostic guidelines compiling insulin 
cut- offs values and dynamic testing interpretations have not been reported for this 
species.
Objectives: To evaluate resting serum insulin concentrations, the combined glucose- 
insulin test (CGIT) and the glucose intravenous tolerance test (IVGTT) for the diagno-
sis of DMS with ID suspicion.
Study design: Diagnostic test comparison.
Methods: Six of 80 mix- breed adult donkeys fulfilled the inclusion criteria for DMS 
based on history or clinical evidence of recurrent laminitis, body condition >6 and 
neck score >2 or baseline insulin and leptin concentrations >20 µIU/mL and >12 ng/
mL respectively. CGIT and IVGTT were performed in all donkeys within a week and 
interpreted following guidelines reported for equine metabolic syndrome (EMS). 
Insulin and glucose curves were analysed, proxies calculated and correlations and 
multivariate analysis assessed.
Results: Following EMS guidelines, CGIT classified 2 (using glucose- positive phase 
duration) or 3 (using insulin concentration) and IVGTT classified 5 donkeys as ID. ID 
donkeys showed a lower glucose/insulin ratio, QUICKI and RISQI, and a higher insu-
lin/glucose ratio, MIRG and HOMA- B%.
Main limitations: Comparison of these tests with additional dynamic testing includ-
ing a larger number of ID donkeys is necessary.
Conclusions: This is the first study evaluating dynamic tests to assess ID/DMS in 
DMS- suspected donkeys. IVGTT detected more ID donkeys than CGIT. EMS recom-
mendations could also be used for DMS diagnosis, although a baseline insulin cut- off 
value is needed.
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1  | INTRODUC TION
Interest in donkeys has been increasing in recent years in developed 
countries, in particular related to assisted therapies for people with 
psychomotor and mental disabilities, as an alternative source of milk 
for people with cow's milk intolerance, in certain sport competitions 
and as companion animals.1 Donkeys are afflicted by similar pathol-
ogies as horses; however, due to physiological and pharmacologi-
cal differences between donkeys and horses,2- 4 a species- specific 
approach should be considered when dealing with diagnostics and 
therapies in donkeys.
While metabolic and endocrine disturbances are common in 
donkeys,5- 8 most studies in this area have been on equine metabolic 
syndrome (EMS),9,10 with donkey- specific knowledge being sparse. 
As a result, clinicians often extrapolate from horses, which in some 
instances apply while in others could lead to misdiagnosis, inappro-
priate treatments and associated risks.
Donkey/Asinine metabolic syndrome (DMS or AMS) is a frequent 
endocrinopathy in this species. Factors contributing to DMS include 
genetic predisposition to obesity due to calm behaviour, energy ef-
ficiency (thrifty species), reduced physical activity and poor nutri-
tional management.11,12
Most research on insulin dysregulation (ID) has been on the di-
agnosis of EMS, with guidelines being updated frequently.13- 15 The 
body condition score (BCS) and baseline insulin, triglyceride, leptin 
and/or adiponectin concentrations are used in the diagnosis and 
management of EMS.16,17 However, the value of these clinical, met-
abolic and endocrine parameters in the diagnosis of DMS remains 
unclear. Dynamic tests are useful for EMS diagnosis,16 but to date 
only the frequently sampled intravenous glucose- insulin tolerance 
test (FSIGT), which is tedious and expensive, has been evaluated in 
donkeys with ID.18 Other dynamic tests have not been characterised 
in donkeys (eg intravenous insulin test [IVITT] and oral glucose tol-
erance test [OGTT]) or have only been assessed in healthy donkeys 
(eg combined glucose- insulin test [CGIT] and intravenous glucose 
tolerance test [IVGTT]).19
We hypothesised that donkeys have specific glucose and in-
sulin disposal particularities that could misdiagnose the DMS 
diagnosis if equine reference values are used. Therefore, the ob-
jective of this study was to evaluate two of the commonly used 
dynamic tests for the diagnosis of EMS (CGIT and IVGTT) in DMS- 
suspected donkeys.
2  | MATERIAL S AND METHODS
2.1 | Animals and inclusion criteria
Eighty donkeys from two donkey sanctuaries were initially evalu-
ated. Inclusion criteria for DMS phenotypically suspected were as 
follows: body condition score (BCS) higher than 6, a neck score (NS) 
higher than 2 and evidence of recurrent laminitis.20 Blood samples 
were drawn from animals fulfilling the inclusion criteria (n = 12) 
and serum insulin (human insulin RIA kit [Millipore Corporation]) 
and leptin (Multi- species Leptin RIA kit [Millipore Corporation]) 
concentrations measured at the Animal Health Diagnostic Center 
from Cornell University using immunoradiometric assays. Animals 
with baseline serum insulin and/or leptin concentrations higher 
than 20 µIU/mL and 12 ng/mL, respectively, were further consid-
ered suspects of having DMS according to the guidelines for EMS 
diagnosis.15- 17,21
Donkeys meeting clinical and endocrine inclusion criteria (n = 6) 
were considered DMS suspected and selected for dynamic tests. 
Animals were housed in a paddock (Brazos Valley Equine Hospital), 
where studies were carried out. Donkeys had free access to water 
and pasture. Donkeys were considered healthy based on physical 
examination and were under a regular deworming and vaccinations 
programmes.
This study received approval from both local and regional wel-
fare committees, and animals were handled according to guidelines 
for research animals.
2.2 | Body morphometric measurements
Morphometric variables included: calculated bodyweight (BW), body 
mass index (BMI), body condition score (BCS), neck score (NS), neck 
circumference (NC) and neck circumference- to- height ratio (NCHR) 
following formulas previously described for donkeys and horses.22,23 
Three independent evaluators graded BCS and NS. The BCS ranged 
from 1 (very thin) to 9 (obese) and the NS from 0 to 4.3,22
2.3 | Testing protocols and interpretation
Donkeys were housed overnight (22:00 pm– 08:00 am) with a flake of 
coastal Bermuda grass hay (1.5 kg) and free access to water.13,14,15,17 
The CGIT and IVGTT were performed to assess ID as previously de-
scribed for donkeys.11,19
Briefly, for the CGIT, dextrose (150 mg/kg bwt; 50% dextrose 
solution [VetOne, MWI Animal Health]) was administered intrave-
nously as a bolus, followed by recombinant human insulin (0.1 IU/
kg bwt; Novolin® N [Novo Nordisk]) as an intravenous bolus. For the 
IVGTT, dextrose (300 mg/kg bwt; 50% dextrose solution [VetOne, 
MWI Animal Health]) was administered intravenously as a bolus. 
Blood samples in both tests were collected at the following time 
points: baseline, 5, 15, 30, 45, 60, 75, 90, 120, 150, 180, 210, 240 
and 300 minutes. Test were carried out in all animals with 1 week 
washout period between tests. All tests were performed in summer 
time.
Based on criteria for EMS dynamic testing interpretation,16,17,24- 26 
donkeys were considered ID positive either when the glucose- 
positive phase was longer than 45 minutes or plasma insulin concen-
trations were higher than 100 µIU/mL by 45 minutes in the CGIT, or 
when glucose and insulin concentrations did not return to baseline 
values after 2 hours for the IVGTT.
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2.4 | Sample handling and measurement
A catheter was placed in the left jugular vein the day before of every 
study in all donkeys. Blood samples were collected into heparin- 
containing tubes for insulin and leptin and into oxalate tubes for 
glucose measurement. After collection, blood samples were chilled 
immediately on ice, subsequently centrifuged at 1500 g for 10 min-
utes at 4℃, aliquoted and stored at −20℃ until analysis.
Every parameter was determined using tests and protocols pre-
viously validated for donkeys.7,11 Plasma insulin (sensitivity limit 
2.7 µIU/mL and intra- assay CV <4.4%) concentration was mea-
sured with a human- specific immunoradiometric assay (DIASource 
ImmunoAssays SA) and glucose by spectrophotometry (Heska Dry- 
Chem 7000 [Fujifilm, Minato- Ku]).
2.5 | Proxies and curves parameters calculation
Fasting baseline glucose and insulin concentrations were used to 
calculate the following proxies according to formulas previously 
used in donkeys and horses27,28: glucose/insulin ratio, insulin/glu-
cose ratio, modified insulin- to- glucose ratio (MIRG), reciprocal of the 
square root of insulin (RISQI), quantitative insulin- sensitivity check 
index (QUICKI), homeostasis model assessment for insulin resistant 
(HOMA- IR) and homeostasis model assessment of percentage β- cell 
function (HOMA- B%).
Parameters obtained from dynamic tests curves have been pre-
viously described in donkeys and horses11,19,29,30: positive phase du-
ration (PPD), positive glucose clearance rate (PGCR), negative phase 
duration, start to nadir interval, nadir concentration, valley duration 
(when applicable), negative glucose clearance rate and valley to 
baseline interval. The areas under the curve for glucose (AUCg) and 
insulin (AUCi) were calculated using the trapezoidal method.11,19,30
2.6 | Data analysis
Normality was assessed with the Shapiro- Wilk test. Data were nor-
mally distributed. Results are expressed as mean and standard devia-
tion. Correlations were calculated using Pearson test. Binary logistic 
regression was used to determine the odds of ID based on the vari-
ables (predictors) studied. Statistical analysis was performed using a 
commercial statistical software (IBM SPSS Statistics 24 [IBM]).
3  | RESULTS
3.1 | Morphometric variables, basal concentrations 
and proxies results
Six mix- breed adult donkeys (1 jack and 5 nonpregnant jennies, 
35 ± 12.1 years old), weighting 218.5 ± 52.9 kg, fulfilled the in-
clusion criteria. All donkeys were obese with a BCS >6 and NS >2 
(Table 1). All donkeys were normoglycaemic, with insulin and leptin 
concentrations (Table 2) higher than reference values reported for 
healthy donkeys and horses,3,31,32 except for donkey 4, which was 
phenotypically suspected and fulfilled most criteria but had a base-
line insulin concentration lower than 20 µIU/mL. Baseline insulin and 
leptin concentrations from donkeys excluded from the study (6/12) 
are shown in Table S1. Ratios and proxies are listed in Table 2.
Glucose and insulin concentrations were negatively correlated 
(Table 3) with bodyweight (r = −0.89, P = .01; r = −0.81, P = .04, 
respectively) and NS (r = −0.99, P < .01; r = −0.77, P = .05, respec-
tively). Pearson correlations among baseline glucose, insulin and 
leptin concentrations and proxies are shown in Table 3.
3.2 | Combined glucose- insulin test
No donkey had adverse effects from the tests. Glucose concentra-
tions peaked (approximately 200% of basal glucose concentrations) 
between 1 and 10 minutes (blood sample collected at 5 minutes) 
in all donkeys. Based on the EMS guidelines for CGIT,16,17,33 only 2 
donkeys (2/6) were classified as ID positive using PPD. When insu-
lin cut- off values were used, 3/6 animals were ID positive (Figure 1; 
Table 4A). Those diagnosed as ID positive based on PPD have a PGCR 
lower than 1.5 mg/dL/min. In contrast, when insulin concentration 
was used, donkeys with ID had an AUCi higher than 25 × 103 mg/
dL/min (Table 5).
Baseline insulin concentration was positively correlated 
(Table S2) with PPD (r = 0.79, P < .05), AUCg (r = 0.95, P < .01) and 
AUCi (r = 0.81, P < .05). The binary logistic regression analysis did 
not identify any variable as a predictor for ID using the CGIT.
3.3 | Intravenous glucose tolerance test
No adverse effects were observed with this test. Glucose adminis-
tration induced an increase in plasma glucose above 250% of basal 
concentration, peaking by 5 minutes. Five of 6 donkeys (5/6) were ID 
positive with the IVGTT (Figure 2; Table 4A) following the protocol 
interpretation previously reported for horses.24,25 Donkeys showed 
an AUCg higher than 32 × 103 mg/dL/min, and a PGCL lower than 
1.5 mg/dL/min (Table 5).
Baseline glucose, insulin and leptin concentrations were posi-
tively correlated (Table S3) with PPD (r = 0.79, r = 0.82 and r = 0.80, 
P < .05; respectively). Also insulin and leptin concentrations were 
negatively correlated with PGCR (r = −0.84 and r = −0.91, P < .05; 
respectively). The binary logistic regression analysis did not identify 
any variable as a predictor for ID using IVGTT.
4  | DISCUSSION
Contrary to horses, there are no validated protocols for DMS di-
agnosis in donkeys. ID criteria described for horses were used to 
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assess the donkeys of this study16,17,21. Results showed differences 
between both dynamic tests, with the CGIT detecting a lower num-
ber of ID donkeys compared with IVGTT.
Based on the results of this study, when dynamic tests are in-
dicated to confirm DMS/AMS, such as donkeys with a moderate 
increase in insulin concentrations (eg 20- 50 µIU/mL), it would be 
preferable to use the IVGTT over the CGIT. Following horse en-
docrine interpretation,16,26 CGIT identified 2/6 (using PPD) or 3/6 
(using insulin concentration by 45 minutes) ID- positive donkeys, 
while IVGTT identified 5/6. Moreover, using a donkey- specific curve 
analysis based on reference values from healthy donkeys,19 the num-
ber of donkeys identified as ID positive decreased to 2/6 with CGIT, 
using both PPD (median: 41.4 minutes) or insulin concentration by 
45 minutes (Table 4B). Despite these findings, all donkeys included in 
this study had a higher AUCg and AUCi values than previously pub-
lished for healthy ones (median: 15.9 × 103 mg/dL/min and 14 × 103 
μIU/mL/min, respectively).19 Therefore, additional factors likely 
influenced the response to the CGIT when used in donkeys with a 
moderate increase in insulin concentrations.
The IVGTT classified a higher number of donkeys as ID (5 of 6), 
both using the interpretation described for horses (PPD >120 min-
utes)24,25 and a donkey- specific approach (PPD >150 minutes; 
Table 4). Donkeys with ID had IVGTT curve parameters different 
from those published for healthy donkeys,19 with longer PPD (me-
dian healthy: 156.3 minutes) and higher AUCg (median healthy: 
21.4 mg/dL/min) and AUCi (median healthy: 7.2 μIU/mL/min).19
Although the IVGTT classified a larger number of donkeys as 
ID, it has the disadvantage that it is more time- consuming.19 In this 
sense, other criterion could be proposed for a faster interpretation; 
for instance, to the author's knowledge, an insulin cut- off at a certain 
time of the curve has not been established for donkeys or horses 
for this test, but could be validated as an earlier indicator of ID. For 
example, a cut- off of 100 µIU/mL at 45 minutes could be used, short-
ening the test duration as done during CGIT. Applying this new crite-
rion to IVGTT, all donkeys were ID positive except donkey 4 (which 
did not fulfil the basal insulin criterion and was ID negative) and don-
key 6. This last animal, despite fulfilling the inclusion criteria, had a 
baseline insulin concentration <20 µIU/mL on the day of the test,25 
which could have caused a lower AUCi despite being positive for ID 
(PPD >120- 150 minutes; Table 5). Increasing the number of donkeys 
with ID doing this test is necessary to validate this criterion.
The CGIT evaluates tissue insulin sensitivity while IVGTT also 
assesses β- cell sensitivity and glucose disposal. A previous study in 
healthy donkeys showed that the IVGTT curve is right shifted and 
displayed a negative phase, indicating delayed insulin sensitivity, al-
though glucose clearance rate was similar to horses.19 Therefore, we 
TA B L E  1   Morphometric measurements for each donkey (n = 6)
Parameter Donkey 1 Donkey 2 Donkey 3 Donkey 4 Donkey 5 Donkey 6 Mean ± SD
BW (kg) 131.9 223.6 215.9 252.2 269.0 160.7 218.5 ± 52.9
BCS 6 8 7 7 9 7 7.4 ± 1.1
BMI (kg/m2) 125.3 204.2 169.8 142.4 204.1 150.0 169.1 ± 35.7
NC (cm) 64.1 71.1 72.1 82.2 83.3 65 74.6 ± 8.1
NS 2 3 3 3 3 2 2.8 ± 0.5
NCHR (cm/m) 62.5 67.9 63.9 61.8 72.6 62.8 65.7 ± 4.5
Abbreviations: BCS, body condition score; BMI, body mass index; BW, bodyweight; NC, neck circumference; NCHR, neck circumference- to- height 
ratio; NS, neck score; SD, standard deviation.
TA B L E  2   Biochemical variables and proxies for each donkey (n = 6)
Variable Donkey 1 Donkey 2 Donkey 3 Donkey 4 Donkey 5 Donkey 6 Mean ± SD
Glucose (mg/dL) 93.5 79.0 79.0 77.5 78.0 98.0 82.1 ± 6.2
Insulin (µIU/mL) 42.4 26.9 20.4 13.8 23.8 30.6 24.6 ± 11.9
Leptin (ng/mL) 24.0 44.9 41.1 22.9 28.2 38.6 32.2 ± 10.1
Glucose/insulin ratio 2.2 2.9 3.9 8.2 3.3 3.2 4.1 ± 2.4
Insulin/glucose ratio 0.45 0.34 0.26 0.12 0.30 0.31 0.30 ± 0.12
RISQI 0.15 0.19 0.22 0.33 0.21 0.18 0.22 ± 0.10
MIRG 12.3 13.1 10.9 6.4 12.4 10.1 11.1 ± 2.70
QUICKI 0.28 0.30 0.31 0.35 0.31 0.29 0.31 ± 0.02
HOMA- IR 175.9 94.7 71.6 32.4 82.4 133.4 91.4 ± 52.8
HOMA- B% 9.4 7.1 5.4 2.5 6.4 6.5 6.2 ± 2.5
Abbreviations: HOMA- B%, homeostasis model assessment of percentage β- cell function; HOMA- IR, homeostasis model assessment for IR; MIRG, 
modified insulin- to- glucose ratio; QUICKI, quantitative insulin- sensitivity check index; RISQI, reciprocal of the square root of insulin; SD, standard 
deviation.
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F I G U R E  1   Glucose (continuous line) 
and insulin (dashed line) concentrations 
for combined glucose- insulin test (CGIT) 
in each donkey. From A to F correspond to 



























































































































































































































































































































TA B L E  4   Insulin dysregulation diagnosis (n = 6) following previously reported guidelines for (A) equine metabolic syndrome16,17,24,25,26 or 
(B) according to donkey- specific dynamic testing interpretation19
Test Donkey 1 Donkey 2 Donkey 3 Donkey 4 Donkey 5 Donkey 6
InterpretationInclusion criteria + + + + + +
(A)
CGIT + + − − − − PPD >45 min
CGIT + + + − − − Insulin >100 μIU/mL by 45 min
IVGTT + + + − + + PPD >120 min
(B)
CGIT + + − − − − PPD >60 min
CGIT + + − − − − Insulin >100 μIU/mL by 60 min
IVGTT + + + − + + PPD >150 min
Abbreviations: CGIT, combine glucose- insulin test; IVGTT, intravenous glucose tolerance test; PPD, positive phase duration.
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can speculate that discrepancies between CGIT and IVGTT could be 
attributed to differences in ID severity in the donkeys included and/
or to the sensitivity of each dynamic challenge. Thus, based on the 
results of this study, the IVGTT should be considered for donkeys 
with suspected mild ID and the CGIT for more severe ID. Moreover, 
evaluation of the enteroinsular axis in donkeys could add valuable 
information on how intestinal factors influence insulin secretion in 
this species.34 In addition to low sensitivity, the CGIT also has poor 
repeatability in horses,35 which has not been evaluated in donkeys 
but could have influenced our results.
Although proxies offer minimal advantages in EMS diagnosis,14,15 
they could be a complementary tool for the diagnosis of DMS/AMS 
and enhance our understanding on energy dynamics in this species. 
In fact, correlations between proxies and an ID- positive diagnosis 
using IVGTT (but not CGIT) were observed, and every ID- positive 
donkey showed proxies outside the reference ranges for this spe-
cies.19 A glucose/insulin ratio <4 was observed in all ID- positive 
donkeys in this study, which is lower than the value proposed for 
horses (<10) regardless of the severity of ID.36 According to our 
results, this cut- off for this proxy could be proposed as a satisfac-
tory tool for ID diagnosis in this species. Similarly, MIRG >10 or 
RISQI <0.22 values could also be proposed for the diagnosis of ID 
in donkeys, being different from those proposed for horses (<5.6 
and <0.32 respectively).17,36 The greatest difference with previously 
described donkeys reference ranges was for HOMA- IR, where ID- 
positive donkeys have a value >70 versus >30 in healthy donkeys,19 
although donkeys in our study were older. Since cut- off values for 
proxies were generated using a low number of donkeys, it would be 
advisable to repeat the study in a larger population of donkeys with 
different degrees of ID to confirm their clinical utility.
Although donkey 4 had a baseline insulin concentration lower 
than 20 µIU/mL, it was included in the study based on the rest of the 
inclusion criteria. However, based on both dynamic tests, it was later 
classified as not having ID. While this was observed in one animal, it 
suggests that insulin is the main laboratorial parameter to consider 
when facing an ID diagnosis. Future studies in larger donkey popula-
tions with different ID degrees using other laboratorial parameters 
to assess EMS such as adiponectin or protein C concentrations15 de-
serve investigation.
It has been shown that baseline insulin concentration had a poor 
sensitivity to diagnose ID,10,37 which could explain why some of don-
keys in this study have contradictory results when using dynamic 
tests. Although species- specific insulin cut- off value cannot be ac-
curately established with our results, it seems reasonable to propose 
that baseline insulin concentrations higher than 20 µIU/mL in fed 
donkeys make the animal suspicious of DMS/AMS, as described in 
the EMS guidelines.15 Future studies with a larger donkey population 
with different ID degrees could evaluate this value. Olley et al (2019) 
TA B L E  5   Analysis of the CGIT and IVGTT curves for each donkey (n = 6)
Parameter Donkey 1 Donkey 2 Donkey 3 Donkey 4 Donkey 5 Donkey 6
CGIT Positive phase duration (min) >300 81.4 37.1 18.5 35.8 27.1
Positive glucose clearance rate (mg/dL/min) 0.2 1.1 2.4 3.7 1.7 4.4
Negative phase duration (min) — 218.6 172.9 156.5 144.2 272.9
Start- to- nadir interval (min) — 120 90 75 75 90
Nadir (mg/dL) — 63 42 22 52 44
Valley duration (min) — 45 60 60 60 60
Negative glucose clearance rate (mg/dL/min) — −0.5 −0.7 −0.9 −0.7 −1.1
Valley- to- baseline interval (min) — 180 120 100 105 210
AUC glucose (×103 mg/dL/min) 35.9 26.1 23.2 19.1 23.8 25.4
AUC insulin (×103 mg/dL/min) 41.7 31.1 25.7 14.7 21.1 19.5
IVGTT Positive phase duration (min) 300 198.7 255 90 161.5 300
Positive glucose clearance rate (mg/dL/min) 0.4 0.9 0.7 2.1 1.5 0.6
Negative phase duration (min) — 101.2 45 210 42.5 — 
Start- to- nadir interval (min) — 240 300 150 180 — 
Nadir (mg/dL) — 60 75 69 67 — 
Valley duration (min) — — — 60 30 — 
Negative glucose clearance rate (mg/dL/min) — −0.4 −0.1 −0.2 −0.4 — 
Valley- to- baseline interval (min) — — — 150 24 — 
AUC glucose (×103 mg/dL/min) 40.1 35.1 37.9 29.6 32.3 48.3
AUC insulin (×103 mg/dL/min) 27.9 35.5 29.1 4.8 21.9 8.6
Note: Positive phase duration: time glucose returned to baseline; positive glucose clearance rate: ratio between the difference in the highest glucose 
concentration minus glucose concentration returned to baseline and time glucose returned to baseline minus time of baseline glucose; Start- to- nadir 
interval: time glucose returned to baseline.
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reported that a lower insulin cut- off (5.2 µIU/mL) would have better 
sensitivity, although worse specificity, compared to 20 µIU/mL.38 
However, this study was carried out in animals fasted for 8- 12 hours, 
using chemiluminescent assay and the cut- off value obtained in-
cluded horses and ponies. A recent study in fasted healthy donkeys 
showed that feed deprivation for 12 hours induced changes in in-
sulin homeostasis39; thus, fasting and duration of fasting alter the 
response to dynamic tests and should be considered in data inter-
pretation in donkeys.
A major factor to take into account in data interpretation and 
clinical classification is the method used for insulin measure-
ment. A number of validated immunoassays are used to measure 
insulin concentrations in horses and results are not equivalent 
among assays.15 This issue has not been investigated in donkeys. 
Thus, in addition to species differences, cut- off values should be 
assay specific as extrapolation may result in misclassification; in 
particular, when insulin concentrations are close to cut- off values. 
This is important as both false- positive and false- negative results 
have clinical and economic implications. Further studies are nec-
essary to evaluate if the proposed insulin cut- off for immunora-
diometric assays is valid when ELISA or chemiluminescent assays 
are used.
It has been shown in horses that season (β- cell sensitivity), 
circadian rhythm, diet (structural carbohydrate content), fasting, 
stress, α2- adrenergic agonists and pregnancy could influence en-
docrine variable and response to dynamic tests.28,30,38,40- 42 Since 
all baseline samples for the inclusion criteria were collected in the 
morning in early July, all dynamic tests were performed in the last 
2 weeks of July, all animals were kept in the same facility under a 
feeding protocol similar to the farm of origin, stress was reduced 
and no treatments were administered; these factors could be 
discarded.
F I G U R E  2   Glucose (continuous line) 
and insulin (dashed line) concentrations 
for intravenous glucose tolerance test 
(IVGTT) in each donkey. From A to F 
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It is important to highlight some shortcomings from this study, 
in particular that a small number of donkeys with moderate ID (in-
sulin concentration <50 µIU/mL) were included. Further studies 
with a larger population of donkeys with varying degrees of ID 
would yield valuable information. In addition, since age affects in-
sulin sensitivity in absence of ID, comparing these results with a 
case- control group of healthy young and old donkeys would be 
compelling.
In conclusion, guidelines for EMS diagnosis could also be useful 
for DMS/AMS diagnosis. Based on our results, the IVGTT identified 
more donkeys with ID than the CGIT. Additional dynamic studies in 
a larger population of healthy and ID donkeys will provide valuable 
insight on the pathogenesis of DMS as well as practical diagnostic 
methods and an insulin cut- off value.
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